// App-Quantinova.ai

: Refining the serum miR-371a-3p test for viable germ cell tumor detection: Identification and definition of an indeterminate range.

Researchers

Presenter

  • Aditya Bagrodia

Principal Investigators

  • John T. Lafin

  • Cinzia Scarpini

  • Bendu Konneh

  • Thomas Gerald

  • Michelle Nuno

  • Jin Piao

  • Anna Savelyeva

  • Liwei Jia

  • Sarah Murray

  • Yun Cheng

  • Vitaly Margulis

  • Solomon L. Woldu

  • Nicholas Coleman

  • James F. Amatruda

  • Lindsay Lindsay Frazier

  • Matthew Murray

Medical Centers

  • UT Southwestern, Dallas, TX

  • Children's Oncology Group, Monrovia, CA

  • Children's Hospital Los Angeles Department of Pediatrics, Los Angeles, CA

  • Dana-Farber Cancer Institute, Boston, MA

  • University of Cambridge, Cambridge, United Kingdom

  • The University of Texas Southwestern Medical Center, Dallas, TX

  • Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

  • University of California, San Diego, La Jolla, CA

  • UC San Diego, La Jolla, CA

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Germ cell tumor

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Superiority

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved